Neuropsychiatry is the most demanding specialty in pharmaceutical medicine — and arguably the most underserved in India. Epilepsy affects over 10 million people, the majority of whom receive no treatment or inadequate treatment. Depression and anxiety disorders affect hundreds of millions. Schizophrenia, bipolar disorder, neuropathic pain — each carries an enormous burden and an enormous treatment gap.
What makes neuropsychiatry particularly challenging from a pharmaceutical standpoint is the nature of the drugs involved. Anti-convulsants, antidepressants, antipsychotics and mood stabilisers are narrow therapeutic index medications — drugs where the difference between a therapeutic dose and a toxic or subtherapeutic dose is small, and where bioavailability consistency is directly linked to clinical outcomes. A neuropsychiatry patient stabilised on a well-manufactured formulation can experience breakthrough symptoms, seizures or serious adverse effects if switched to a substandard generic.
Quinek Life Sciences is a WHO-GMP certified neuropsychiatry pharmaceutical company in India — built for the clinical precision this specialty demands. This article explains our portfolio, our quality standards and why neurologists, psychiatrists and general practitioners across India trust Quinek as their neuropsychiatry pharma partner.
IN THIS ARTICLE
- The Neuropsychiatry Disease Burden in India
- Why Quality Certification Is Critical in Neuropsychiatry
- Anti-Convulsant Range — Epilepsy Management
- Neuropathic Pain & Nerve Support Range
- Psychiatry Range — Depression, Anxiety & Psychosis
- Neurovitamins & Supportive Range
- Why Neurologists & Psychiatrists Choose Quinek
- Why Distributors Choose Quinek for Neuropsychiatry
- Partner With Quinek Life Sciences
The Neuropsychiatry Disease Burden in India
India bears one of the largest neuropsychiatric disease burdens in the world — and the treatment gap in this specialty is among the widest. Stigma, inadequate specialist availability (India has fewer than 1 neurologist per 100,000 population in most states), high medication costs and a cultural reluctance to seek psychiatric care all compound the challenge.
Why Quality Certification Is Critical in Neuropsychiatry
Neuropsychiatry pharmaceuticals are not like most other drug categories. Anti-convulsants, antidepressants and antipsychotics are narrow therapeutic index drugs — the window between a dose that works and a dose that causes toxicity or fails to control symptoms is narrow. This makes bioavailability consistency not a quality preference but a patient-safety requirement.
CRITICAL CLINICAL POINT
A patient with epilepsy who has been seizure-free for 12 months on a well-manufactured Sodium Valproate can experience a breakthrough seizure if switched to a generic with inconsistent dissolution — even at the same labelled dose. The brand of anti-convulsant matters clinically, not just commercially. Reference: Epilepsy Foundation — Anti-Seizure Medicine Substitution and Bioavailability
Anti-Convulsants
Narrow therapeutic index — serum level fluctuations from inconsistent bioavailability cause breakthrough seizures or toxicity.
Antidepressants
Inconsistent potency delays therapeutic response or causes adverse effects — extending patient suffering in an already stigmatised condition.
Antipsychotics
Dosing precision is critical — underdosing risks relapse, overdosing risks serious extrapyramidal and metabolic adverse effects.
Pregabalin / Gabapentin
Controlled substances in India — manufacturing standards, traceability and consistent release profiles are regulatory and clinical requirements.
Anti-Convulsant Range — Epilepsy Management
Our anti-convulsant portfolio is built around the most clinically relevant anti-seizure medicines in Indian neurological practice — with formulations that cover both broad-spectrum and focal epilepsy, in multiple dosage forms designed to support adherence and bioavailability consistency.
SEIZURE TYPE — MEDICINE SELECTION GUIDE
Generalised Tonic-Clonic
DPROKS · ALPOR 500 · EVETAM-P
Absence Seizures
DPROKS · ALPOR 500
Myoclonic Seizures
DPROKS · EVETAM-P
Focal Seizures
EVETAM-P · DPROKS · P2M (adjunct)
Neuropathic Pain & Nerve Support Range
Neuropathic pain is one of the most prevalent and most undertreated conditions in Indian clinical practice — affecting diabetic patients, post-herpetic neuralgia patients, patients with radiculopathy and those with chemotherapy-induced neuropathy. Our neuropathic pain range combines proven pharmaceutical agents with nerve support nutrients for comprehensive clinical management.
QUINEK NEUROPATHIC PAIN RANGE
P2M — Pregabalin 75mg + Methylcobalamin 750mcg
First-line neuropathic pain · Diabetic neuropathy · Post-herpetic neuralgia · Nerve regeneration support
NIXCHEL-NT — Pregabalin 75mg + Methylcobalamin 750mcg + Nortriptyline
Combination neuropathic pain management · Central sensitisation · Sleep disturbance from neuropathic pain
WHO-GMP certified · Consistent pregabalin release profile · Schedule H controlled substance compliance
Psychiatry Range — Depression, Anxiety & Psychosis
Our psychiatry portfolio covers the core pharmacological needs of a practising psychiatrist — antidepressants, anxiolytics and antipsychotics — manufactured under WHO-GMP certification to deliver the consistency that psychiatric patients, who are among the most adherence-dependent in clinical medicine, require.
Neurovitamins & Supportive Range
Neurological patients frequently have nutritional deficiencies that directly worsen their primary condition — B12 deficiency worsens peripheral neuropathy, folate deficiency interacts with anti-convulsant therapy, and micronutrient deficits impair cognitive function. Our neurovitamin range provides certified, high-quality supplementation as part of a comprehensive neuropsychiatry management strategy.
NEUROVITAMIN & SUPPORTIVE COVERAGE
Methylcobalamin (B12) formulations · High-dose nerve regeneration support
Folic acid supplementation · Critical in patients on anti-convulsants (valproate reduces folate levels)
Alpha Lipoic Acid combinations · Antioxidant neuroprotection
Multivitamin-multimineral neurological support combinations
WHO-GMP · FSSAI certified · Nutraceutical and pharmaceutical grade manufacturing
Why Neurologists & Psychiatrists Choose Quinek
Why Distributors Choose Quinek for Neuropsychiatry
Neuropsychiatry is among the highest-value specialty pharma segments in India — and one of the fastest growing, driven by increasing mental health awareness, expanding epilepsy treatment penetration and a growing neuropathic pain patient base. For distributors and C&F agents, partnering with a certified neuropsychiatry company offers consistent, long-term prescription volume from a patient cohort that requires lifelong medication management.
FOR DISTRIBUTION PARTNERS
Long-term patient adherence — neuropsychiatric patients require ongoing medication, creating reliable recurring prescription volume
High-value specialty segment — neuropsychiatry prescriptions come from neurologists, psychiatrists and GPs with high prescription frequency
WHO-GMP protection — certified formulations protect distributors from regulatory risk and quality incidents
Growing market — mental health awareness, epilepsy treatment penetration and neuropathic pain management are all expanding in India
Full portfolio advantage — anti-convulsants + antidepressants + neuropathic pain + neurovitamins enables broad territory coverage from one partner
“70% of people with epilepsy could be seizure-free. The medicines exist. What they need is quality — and access.”
Quinek Life Sciences — WHO-GMP Certified Neuropsychiatry Pharma Company, India
Epilepsy · Depression · Anxiety · Psychosis · Neuropathic Pain
References & Further Reading
- World Health Organization — Epilepsy Fact Sheet, 2023
- WHO — Mental Disorders Fact Sheet, 2023
- International League Against Epilepsy — Definition and Classification, 2014
- Epilepsy Foundation — Anti-Seizure Medicine Substitution and Bioavailability
- Neurology India — Epilepsy Burden and Treatment Gap in India
- WHO — Good Manufacturing Practices for Pharmaceuticals
- Quinek Life Sciences — Neuropsychiatry Segment
- Quinek Life Sciences — Quality Certifications
This article is for educational and informational purposes. All products are prescription medicines for professional use only. Quinek Life Sciences holds valid WHO-GMP, GLP, ISO, DCGI and FSSAI certifications at the time of publication.
